tapa-pulsed dendritic cells
Vaccineexperimental
Clinical trial activity
4 trials · 1 clinical orgs · 0 marketing orgs
Phase 1
4
Phase 2
4
Phase 3
0
Phase 4
0
Earliest trial started Dec 1, 2016 (NCT02709993)
Timeline
2010s
- Jan 1, 2016
Earliest Phase 1 Sponsor(trial)
Indications
Mechanism of action
- Tumor antigensImmunity, active
Tumor antigens immunity, active
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- tapa-pulsed dendritic cells
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT02223312 | Phase 1/Phase 2 (Phase 2) | Dec 1, 2016 | Kiromic, LLC |
| NCT02224599 | Phase 1/Phase 2 (Phase 2) | Dec 1, 2016 | Kiromic, LLC |
| NCT02705703 | Phase 1/Phase 2 (Phase 2) | Dec 1, 2016 | Kiromic, LLC |
| NCT02709993 | Phase 1/Phase 2 (Phase 2) | Dec 1, 2016 | Kiromic, LLC |
Showing 4 of 4 trials
Page 1 / 1
Organizations
Research & Development (1)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Kiromic, LLC | For profit | 4 | 4 | 1 | 2016 |
1 organizations
Page 1 / 1